Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 May;20(5):781-790.
doi: 10.3348/kjr.2018.0273.

Dynamic Contrast-Enhanced Ultrasound of Gastric Cancer: Correlation with Perfusion CT and Histopathology

Ijin Joo  1 , Se Hyung Kim  2 , Dong Ho Lee  1 , Joon Koo Han  1   3
Affiliations

Dynamic Contrast-Enhanced Ultrasound of Gastric Cancer: Correlation with Perfusion CT and Histopathology

Ijin Joo et al. Korean J Radiol. 2019 May.

Abstract

Objective: To assess the relationship between contrast-enhanced ultrasound (CEUS) parameters and perfusion CT (PCT) parameters of gastric cancers and their correlation with histologic features.

Materials and methods: This prospective study was approved by our Institutional Review Board. We included 43 patients with pathologically-proven gastric cancers undergoing CEUS using SonoVue® (Bracco) and PCT on the same day. Correlation between the CEUS parameters (peak intensity [PI], area under the curve [AUC], rise time [RT] from 10% to 90% of PI, time to peak [TTPUS], and mean transit time [MTTUS]) and PCT parameters (blood flow, blood volume, TTPCT, MTTCT, and permeability surface product) of gastric cancers were analyzed using Spearman's rank correlation test. In cases of surgical resection, the CEUS and PCT parameters were compared according to histologic features using Mann-Whitney test.

Results: CEUS studies were of diagnostic quality in 88.4% (38/43) of patients. Among the CEUS parameters of gastric cancers, RT and TTPUS showed significant positive correlations with TTPCT (rho = 0.327 and 0.374, p = 0.045 and 0.021, respectively); PI and AUC were significantly higher in well-differentiated or moderately-differentiated tumors (n = 4) than poorly-differentiated tumors (n = 18) (p = 0.026 and 0.033, respectively), whereas MTTCT showed significant differences according to histologic types (poorly cohesive carcinoma [PCC] vs. non-PCC), T-staging (≤ T2 vs. ≥ T3), N-staging (N0 vs. N-positive), and epidermal growth factor receptor expression (≤ faint vs. ≥ moderate staining) (p values < 0.05).

Conclusion: In patients with gastric cancers, CEUS is technically feasible for the quantification of tumor perfusion and may provide correlative and complementary information to that of PCT, which may allow prediction of histologic features.

Keywords: Contrast-enhanced ultrasound (CEUS); Histologic grade; Perfusion imaging; Stomach cancer.

PubMed Disclaimer

Conflict of interest statement

The authors have no potential conflicts of interest to disclose.

Figures

Fig. 1
Fig. 1. Calculation of perfusion parameters using CEUS.
AUC = area under curve, CEUS = contrast-enhanced ultrasound, MTT = mean transit time, PI = peak intensity, RT = rise time, TTP = time to peak
Fig. 2
Fig. 2. Sixty-two-year-old male patient with surgically-proven pT2N0 gastric cancer of moderately-differentiated adenocarcinoma.
A. Preoperative contrast-enhanced CT image shows enhancing ulceroinfiltrative mass (arrow) at level of gastric mid body. B. CEUS image shows enhancing mass (arrow, green ROI) at corresponding location of water-distended stomach. C. Time-intensity curve analysis reveals PI of 2619 a.u. and AUC of 48820 a.u. ROI = region of interest
Fig. 3
Fig. 3. Eighty-two-year-old female patient with surgically-proven pT3N0 gastric cancer of poorly-differentiated adenocarcinoma.
A. Axial CT image shows ulceroinfiltrative mass involving gastric low body and antrum (arrows). B. CEUS image reveals mass (arrows, green ROI) showing mild enhancement. C. Time-intensity curve analysis reveals PI of 36.9 a.u. and AUC of 342.0 a.u.
See this image and copyright information in PMC

References

    1. Soerjomataram I, Lortet-Tieulent J, Parkin DM, Ferlay J, Mathers C, Forman D, et al. Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions. Lancet. 2012;380:1840–1850. - PubMed
    1. De Vita F, Giuliani F, Galizia G, Belli C, Aurilio G, Santabarbara G, et al. Neo-adjuvant and adjuvant chemotherapy of gastric cancer. Ann Oncol. 2007;18(Suppl 6):vi120–vi123. - PubMed
    1. Shah MA, Ajani JA. Gastric cancer--an enigmatic and heterogeneous disease. JAMA. 2010;303:1753–1754. - PubMed
    1. Garcia-Figueiras R, Goh VJ, Padhani AR, Baleato-Gonzalez S, Garrido M, Leon L, et al. CT perfusion in oncologic imaging: a useful tool? AJR Am J Roentgenol. 2013;200:8–19. - PubMed
    1. Padhani AR. Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions. J Magn Reson Imaging. 2002;16:407–422. - PubMed

Publication types